✦ LIBER ✦

Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure

✍ Scribed by Jan A.F.M. van der Vring; Peter J.L.M. Bernink; Ernst E. van der Wall; Dirk J. van Velhuisen; Shimon Braun; Isaac Kobrin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Survival After Long-Term Treat

✍ Paul Mulder; PhD; Vincent Richard; PhD; Patricia Compagnon; Jean-Paul Henry; Fra 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 220 KB

The calcium antagonist mibefradil increa

✍ MULDER, P 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 291 KB

Effect of mibefradil, a T-type calcium-c

✍ Ishikawa Kimito; Ohtsuka Sadanori; Yamaguchi Iwao 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Beneficial Effects of T-type Calcium Cha

✍ Satoshi Hirasaki; Masaki Tsukamoto; Koichi Kawata 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Chronic renal and neurohumoral effects o

✍ Jean-Noël Barjon; Jean-Lucien Rouleau; Daniel Bichet; Carl Juneau; Jacques De Ch 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 850 KB

Angiotensin II receptor antagonist impro

✍ T. Tsutamoto; K. Maeda; N. Mabuchi; T. Hisanaga; A. Wada; D. Fukai; M. Ohnishi; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 175 KB